Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 67 (TRIM67) is a Class I TRIM family E3 ubiquitin ligase that is predominantly expressed in the nervous system of mammals, where it regulates neuronal morphogenesis, cytoskeletal dynamics, exocytosis, and synapse maintenance[1][2][3]. TRIM67 interacts with several cytoskeletal and membrane trafficking proteins and is involved in processes critical for neuronal growth and neural circuit formation, such as axon branching, dendritic arborization, and filopodia stability[1][2]. Animal studies demonstrate that loss of TRIM67 leads to pronounced defects in brain structure, connectivity, and cognitive function, with TRIM67 knockout mice exhibiting hippocampal hypotrophy and impairments in spatial memory, social behavior, and sensorimotor gating[2]. TRIM67 does not have any current known drug modulators, nor is it an established therapeutic target in human disease, but it plays a significant role in brain development and function; disruptions may contribute to neurodevelopmental disorders[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 67 (TRIM67).